0 0 Sapphire Healthcare UK Ltd 04687221 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is management consultancy. Digita Accounts Production Advanced 6.30.9574.0 true 04687221 2024-04-01 2025-03-31 04687221 2025-03-31 04687221 core:RetainedEarningsAccumulatedLosses 2025-03-31 04687221 core:ShareCapital 2025-03-31 04687221 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 04687221 core:FurnitureFittingsToolsEquipment 2025-03-31 04687221 bus:SmallEntities 2024-04-01 2025-03-31 04687221 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 04687221 bus:FilletedAccounts 2024-04-01 2025-03-31 04687221 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 04687221 bus:RegisteredOffice 2024-04-01 2025-03-31 04687221 bus:Director1 2024-04-01 2025-03-31 04687221 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04687221 bus:Agent1 2024-04-01 2025-03-31 04687221 core:FurnitureFittings 2024-04-01 2025-03-31 04687221 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 04687221 core:OfficeEquipment 2024-04-01 2025-03-31 04687221 countries:England 2024-04-01 2025-03-31 04687221 2024-03-31 04687221 core:FurnitureFittingsToolsEquipment 2024-03-31 04687221 2023-04-01 2024-03-31 04687221 2024-03-31 04687221 core:RetainedEarningsAccumulatedLosses 2024-03-31 04687221 core:ShareCapital 2024-03-31 04687221 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 04687221 core:FurnitureFittingsToolsEquipment 2024-03-31 xbrli:pure iso4217:GBP

Registration number: 04687221

Sapphire Healthcare UK Ltd

Annual Report and Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

Sapphire Healthcare UK Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 5

 

Sapphire Healthcare UK Ltd

Company Information

Director

Mr M P Byrne

Registered office

8 High Street
Heathfield
East Sussex
TN21 8LS

Accountants

Manningtons 8 High Street
Heathfield
East Sussex
TN21 8LS

 

Sapphire Healthcare UK Ltd

(Registration number: 04687221)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

58

77

Current assets

 

Cash at bank and in hand

 

2,973

2,973

Creditors: Amounts falling due within one year

5

(25,967)

(25,663)

Net current liabilities

 

(22,994)

(22,690)

Net liabilities

 

(22,936)

(22,613)

Capital and reserves

 

Called up share capital

1

1

Retained earnings

(22,937)

(22,614)

Shareholders' deficit

 

(22,936)

(22,613)

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 8 September 2025
 

.........................................
Mr M P Byrne
Director

 

Sapphire Healthcare UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
8 High Street
Heathfield
East Sussex
TN21 8LS
United Kingdom

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The presentation currency of the financial statements is the Pound Sterling (£).

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures & Fittings

25% Reducing Balance

Office Equipment

25% Reducing Balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Sapphire Healthcare UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised at the transaction price.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2024 - 0).

 

Sapphire Healthcare UK Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2024

4,080

4,080

At 31 March 2025

4,080

4,080

Depreciation

At 1 April 2024

4,003

4,003

Charge for the year

19

19

At 31 March 2025

4,022

4,022

Carrying amount

At 31 March 2025

58

58

At 31 March 2024

77

77

5

Creditors

Creditors: amounts falling due within one year

2025
£

2024
£

Due within one year

Accruals and deferred income

601

801

Other creditors

743

345

Director loan account

24,623

24,517

25,967

25,663